Skip to main content
SpringerLink
Log in

Growth inhibitors: Molecular diversity and roles in cell proliferation

  • Invited Review
  • Published:
In Vitro Cellular & Developmental Biology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Akhurst, R. J.; Fee, F.; Balmain, A. Localized production of TGF-β mRNA in tumor promoter-stimulated mouse epidermis. Nature 331:363–365; 1988.

    PubMed  CAS  Google Scholar 

  2. Allen, J. C.; Smith, C. J.; Thomas, J. M., et al. Inhibition of lymphocyte proliferation by polyamines requires ruminantplasma polyamine oxidase. Eur. J. Biochem. 102:153–158; 1979.

    PubMed  CAS  Google Scholar 

  3. Barnard, J. A.; Beauchamp, R. D.; Coffey, R. J., et al. Regulation of intestinal epithelial cell growth by transforming growth factor type β. Proc. Natl. Acad. Sci. USA 86:1578–1582; 1989.

    PubMed  CAS  Google Scholar 

  4. Barnes, D. Epidermal growth factor inhibits growth of A431 human epidermoid carcinoma in serum-free culture. J. Cell Biol. 93:1–4; 1982.

    PubMed  CAS  Google Scholar 

  5. Bishop, J. M. The molecular genetics of cancer. Science 16:305–311; 1987.

    Google Scholar 

  6. Blat, C.; Chatelain, G.; Desauty, G., et al. Inhibitory diffusible factor IDF45, a G1 phase inhibitor. FEBS 203:175–180; 1986.

    CAS  Google Scholar 

  7. Bőhmer, F.-D.; Lehmann, W.; Schmidt, H. E., et al. Purification of a growth inhibitor for Ehrlich ascites mammary carcinoma cells from bovine mammary gland. Exp. Cell. Res. 150:466–476; 1984.

    PubMed  Google Scholar 

  8. Bőhmer, F.-D.; Kraft, R.; Otto, A., et al. Identification of a polypeptide growth inhibitor from bovine mammary gland—sequence homology to fatty acid- and retinoid-binding proteins. J. Biol. Chem. 262:15137–15143; 1987.

    PubMed  Google Scholar 

  9. Bőhmer, F.-D.; Sun, Q.; Műller, T., et al. Antibodies against mammary derived growth inhibitor (MDGI) react with a fibroblast growth inhibitor and with heart fatty acid binding protein. Biochem. Biophys. Res. Commun. 148:1425–1431; 1987.

    PubMed  Google Scholar 

  10. Brandt, R.; Pepperle, M.; Otto, A., et al. A 13-kilodalton protein purified from milk fat globule membranes is closely related to a mammary-derived growth inhibitor. Biochemistry 27:1420–1425; 1988.

    PubMed  CAS  Google Scholar 

  11. Braun, L.; Mead, J. E.; Panzica, M., et al. Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA 85:1539–1543; 1988.

    PubMed  CAS  Google Scholar 

  12. Budzik, G. P.; Powell, S. M.; Kamagata, S., et al. Műllerian inhibiting substance fractionation by dye affinity chromatography. Cell 34:307–314; 1983.

    PubMed  CAS  Google Scholar 

  13. Bullough, W. S.; Laurence, E. B. The control of epidermal mitotic activity in the mouse. Proc. Roy. Soc., B 151:517–536; 1960.

    CAS  Google Scholar 

  14. Bullough, W. S. Growth control in mammalian skin. Nature 193:520–523; 1962.

    PubMed  CAS  Google Scholar 

  15. Carr, B. I.; Hayashi, I.; Branum, E. L., et al. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res. 46:2330–2334; 1986.

    PubMed  CAS  Google Scholar 

  16. Cate, R. L.; Mattaliano, R. J.; Hession, C., et al. Isolation of the bovine and human genes for Műllerian inhibiting substance and expression of the human gene in animal cells. Cell 45:685–698; 1986.

    PubMed  CAS  Google Scholar 

  17. Cheifetz, S.; Weatherbee, J. A.; Tsang, M. L.-S., et al. The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptors. Cell 48:409–415; 1987.

    PubMed  CAS  Google Scholar 

  18. Chen, L.; Mory, Y.; Zilberstein, A., et al. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2. Proc. Natl. Acad. Sci. USA 85:8037–8041; 1988.

    PubMed  CAS  Google Scholar 

  19. Chiang, C.-P.; Nilsen-Hamilton, M. Opposite and selective effects of epidermal growth factor and human platelet transforming growth factor-β on the production of secreted proteins by murine 3T3 cells and human fibroblasts. J. Biol. Chem. 261:10478–10481; 1986.

    PubMed  CAS  Google Scholar 

  20. Childs, C. B.; Proper, J. A.; Tucker, R. F., et al. Serum contains a platelet-derived transforming growth factor. Proc. Natl. Acad. Sci. USA 79:5312–5316; 1982.

    PubMed  CAS  Google Scholar 

  21. Coffey, R. J., Jr.; Basom, C. C.; Sipes, N. J., et al. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol. Cell. Biol. 8:3088–3093; 1988.

    PubMed  CAS  Google Scholar 

  22. de Martin, R.; Haendler, B.; Hofer-Warbinke, R., et al. Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-β gene family. EMBO J. 6:3673–3677; 1987.

    PubMed  Google Scholar 

  23. Dent, P. B.; Liao, S. K.; Ettin, G., et al. Characterization of an inhibitor of thymidine uptake produced by cultured human melanoma cells. Oncology 35:235–241; 1978.

    PubMed  CAS  Google Scholar 

  24. Derynck, R.; Jarrett, J. A.; Chen, E. Y., et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701–705; 1985.

    PubMed  CAS  Google Scholar 

  25. Derynck, R.; Lindquist, P. B.; Lee, A., et al. A new type transforming growth factor-β, TGF-β3. EMBO J. 7:3737–3743; 1988.

    PubMed  CAS  Google Scholar 

  26. Dyson, N.; Howley, P. M.; Műager, K., et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:934–937; 1989.

    PubMed  CAS  Google Scholar 

  27. Edwards, D. R.; Murphy, G.; Reynolds, J. J. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899–1904; 1987.

    PubMed  CAS  Google Scholar 

  28. Elgjo, K.; Reichelt, M. D.; Hennings, H., et al. Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells. J. Invest. Dermatol. 87:555–558; 1986.

    PubMed  CAS  Google Scholar 

  29. Ellingsworth, L. R.; Brennan, J. E.; Fok, K., et al. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor-β immunohistochemical localization and association with differentiating cells. J. Biol. Chem. 261:12362–12367; 1986.

    PubMed  CAS  Google Scholar 

  30. Florini, J. R.; Roberts, A. B.; Ewton, D. Z., et al. Transforming growth factor-β—a very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J. Biol. Chem. 261:16509–16513; 1986.

    PubMed  CAS  Google Scholar 

  31. Hanks, S. K.; Armour, R.; Baldwin, J. H., et al. Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc. Natl. Acad. Sci. USA 85:79–82; 1988.

    PubMed  CAS  Google Scholar 

  32. Harrington, W. N.; Godman, G. C. A selective inhibitor of cell proliferation from normal serum. Proc. Natl. Acad. Sci. USA 77:423–427; 1980.

    PubMed  CAS  Google Scholar 

  33. Heimark, R. L.; Twardzik, D. R.; Schwartz, S. M.; Inhibition of endothelial cell regeneration by type β transforming growth factor from platelets. Science 233: 1078–1080; 1986.

    PubMed  CAS  Google Scholar 

  34. Heldin, C.-H.; Westermark, B. Growth factors: mechanism of action and relation to oncogenes. Cell 37: 9–20; 1984.

    PubMed  CAS  Google Scholar 

  35. Holley, R. W.; Böhlen, P.; Fava, R., et al. Purification of kidney epithelial cell growth inhibitors. Proc. Natl. Acad. Sci. USA 77:5989–5992; 1980.

    PubMed  CAS  Google Scholar 

  36. Hsu, Y.-M.; Wang, J. L.. Growth control in cultured 3T3 fibroblasts, V. Purification of an M, 13,000 polypeptide responsible for growth inhibitory activity. J. Cell Biol. 102:362–369; 1986.

    PubMed  CAS  Google Scholar 

  37. Huang, H.-J.; Yee, J.-K.; Shew, J.-Y., et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563–1566; 1988.

    PubMed  CAS  Google Scholar 

  38. Ignotz, R.; Massagué, J. Type β transforming growth factor controls the adipogenic differentiation of 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 82:8530–8534; 1985.

    PubMed  CAS  Google Scholar 

  39. Ignotz, R.; Endo, T.; Massagué, J. Regulation of bironectin and type I collagen mRNA levels by transforming growth factor-β. J. Biol. Chem. 262:6443–6446; 1987.

    PubMed  CAS  Google Scholar 

  40. Ikeda, T.; Liobin, M. N.; Marquardt, H. Human transforming growth factor type β2: production by a prostatic adenocar-cinoma cell line, purification, and initial characterization. Biochemistry 26:2406–2410; 1987.

    PubMed  CAS  Google Scholar 

  41. Iwata, K. K.; Fryling, C. M.; Knott, W. B., et al. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res. 45:2689–2694; 1985.

    PubMed  CAS  Google Scholar 

  42. Kamata, N.; Chida, K.; Rikimaru, K., et al. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res. 46:1648–1653; 1986.

    PubMed  CAS  Google Scholar 

  43. Kehrl, J. H.; Roberts, A. B.; Wakefield, L. M. Transforming growth factor β is an important immunoregulatory protein for human B-lymphocytes. J. Immunol. 137:3855–3860; 1986.

    PubMed  CAS  Google Scholar 

  44. Kehrl, J. H.; Wakefield, L. M.; Roberts, A. B. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037–1050; 1986.

    PubMed  CAS  Google Scholar 

  45. Kinders, R. J.; Johnson, T. C. Isolation of cell-surface glycopeptides from bovine cerebral cortex that inhibit cell growth and protein synthesis in normal but not in transformed cells. Biochem. J. 206:527–534; 1982.

    PubMed  CAS  Google Scholar 

  46. Koga, T.; Nakano, S.; Ichinose, I., et al. Characterization of a low-molecular-weight growth inhibitor formed by density-inhibited, tumorigenic V79 Chinese hamster cells. Cancer Res. 48:3737–3741; 1988.

    PubMed  CAS  Google Scholar 

  47. Laiho, M.; Saksela, O.; Andreasen, P. A., et al. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J. Cell Biol. 103:2403–2410; 1986.

    PubMed  CAS  Google Scholar 

  48. Lawrence, D. A.; Pircher, R.; Jullien, P. Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions. Biochem. Biophys. Res. Commun. 133:1026–1034; 1985.

    PubMed  CAS  Google Scholar 

  49. Lee, W.-H.; Shew, J.-Y.; Hong, F. D., et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642–645; 1987.

    PubMed  CAS  Google Scholar 

  50. Lenfant, M.; Wdzieczak-Bakala, J.; Guittet, E., et al. Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure. Proc. Natl. Acad. Sci. USA 86:779–782; 1989.

    PubMed  CAS  Google Scholar 

  51. Leof, E. B.; Proper, J. A.; Goustin, A. S., et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 83:2453–2457; 1986.

    PubMed  CAS  Google Scholar 

  52. Lieberman, M. A. The presence of both growth inhibitory and growth stimulatory factors on membranes prepared from mouse liver. Biochem. Biophys. Res. Commun. 120:891–897; 1984.

    PubMed  CAS  Google Scholar 

  53. Like, B.; Massagué, J. The antiproliferative effect of type β transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261:13426–13429; 1986.

    PubMed  CAS  Google Scholar 

  54. Ling, N.; Ying, S.-Y.; Ueno, N., et al. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature 321:779–782; 1986.

    PubMed  CAS  Google Scholar 

  55. Loo, D. T.; Fuquay, J. I.; Rawson, C. L., et al. Extended culture of mouse embryo cells without senescence: inhibition by serum. Science 236:200–202; 1987.

    PubMed  CAS  Google Scholar 

  56. Lumpkin, C. K., Jr.; McClung, J. K.; Pereira-Smith, O. M., et al. Existence of high abundance antiproliferative mRNA's in senescent human diploid fibroblasts. Science. 232:393–395; 1986.

    PubMed  CAS  Google Scholar 

  57. Lyons, R. M.; Keski-Oja, J.; Moses, H. L. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol. 106:1659–1665; 1988.

    PubMed  CAS  Google Scholar 

  58. Mashima, K.; Kimura, T.; Huang, W., et al. Multiple forms of growth inhibitors secreted from cultured rat liver cells: purification and characterization. J. Biochem. 103:1020–1026; 1988.

    PubMed  CAS  Google Scholar 

  59. Mashima, K.; Kimura, T.; Miyazaki, K., et al. Growth-inhibitory protein present in rabbit serum, which is more effective on tumorigenic rat liver epithelial cells than on nontumorigenic ones: its species, and mode of existence. Biochem. Biophys. Res. Commun. 148:1215–1222; 1988.

    Google Scholar 

  60. Mason, A. J.; Hayflick, J. S.; Ling, N., et al. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318:659–663; 1985.

    PubMed  CAS  Google Scholar 

  61. Massagué, J. The TGF-β family of growth and differentiation factors. Cell 49:437–438; 1987.

    PubMed  Google Scholar 

  62. Masui, T.; Wakefield, L. M.; Lechner, J. F., et al. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83:2438–2442; 1986.

    PubMed  CAS  Google Scholar 

  63. Matrisian, L. M.; Leroy, P.; Ruhlmann, C., et al. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol. Cell. Biol. 6:1679–1686; 1986.

    PubMed  CAS  Google Scholar 

  64. McMahon, J. B.; Farrelly, J. G.; Iype, T. Purification and properties of a rat liver protein that specifically inhibits the proliferation of nonmalignant epithelial cells from rat liver. Proc. Natl. Acad. Sci. USA 79:456–460; 1982.

    PubMed  CAS  Google Scholar 

  65. McMahon, J. B.; Richards, W. L.; del Campo, A. A., et al. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 46:4665–4671; 1986.

    PubMed  CAS  Google Scholar 

  66. Miwa, N.; Mizuno, S. Inhibition of tumor cell growth by protein factors derived from the developing mouse brain. J. Cancer Res. Clin. Oncol. 110:196–202; 1985.

    PubMed  CAS  Google Scholar 

  67. Miyazaki, K.; Mashima, K.; Yamashita, N., et al. Characterization of a growth-inhibiting protein present in serum that exerts a differential effect on in vitro growth of nonmalignant rat liver cells when compared with Rous sarcoma virus-transformed rat liver cells. In Vitro Cell. Develop. Biol. 21:62–66; 1985.

    CAS  Google Scholar 

  68. Miyazaki, K.; Mashima, K.; Yamashita, N., et al. Growth regulation of normal and RSV-transformed liver cells of rat by growth inhibitors present in serum. In: Murakami, H.; Yamane, I.; Barnes, D. W., et al., eds. Growth and differentiation of cells in defined environment. Tokyo: Kodansha/Springer-Verlag; 1985:443–448.

    Google Scholar 

  69. Miyazaki, K.; Mashima, K.; Kimura, T., et al. Growth inhibitors in serum, platelets, and normal and malignant tissues. Adv. Enzymol. 26:225–237; 1987.

    CAS  Google Scholar 

  70. Miyazono, K.; Hellman, U.; Wernstedt, C., et al. Latent high molecular weight complex of transforming growth factor β1. Purification from human platelets and structural characterization. J. Biol. Chem. 263:6407–6415; 1988.

    PubMed  CAS  Google Scholar 

  71. Miyazono, K.; Heldin, C.-H. Role for carbohydrate structures in TGF-β1 latency. Nature 338:158–160; 1989.

    PubMed  CAS  Google Scholar 

  72. Mustoe, T. A.; Pierce, G. F.; Thomason, A., et al. Transforming growth factor type β induces accelerated healing of incisional wounds in rats. Science 237:1333–1368; 1987.

    PubMed  CAS  Google Scholar 

  73. Nakamura, T.; Yoshimoto, K.; Nakayama, Y., et al. Reciprocal modulation of growth and differentiated functions of mature rat hepatocytes in primary culture by cell-cell contact and cell membranes. Proc. Natl. Acad. Sci. USA 80:7229–7233; 1983.

    PubMed  CAS  Google Scholar 

  74. Nakamura, T.; Tomita, Y.; Hirai, R., et al. Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem. Biophys. Res. Commun. 133:1042–1050; 1985.

    PubMed  CAS  Google Scholar 

  75. Padgett, R. W.; St. Johnston, R. D.; Gelbart, W. M. A transcript from a Drosophila pattern gene predicts a protein homologous to the transforming growth factor-β family. Nature 325:81–84; 1987.

    PubMed  CAS  Google Scholar 

  76. Patt, L. M.; Houck, J. C. The incredible shrinking chalone. FEBS Lett. 120:163–170; 1980.

    PubMed  CAS  Google Scholar 

  77. Paukovits, W. R.; Laerum, O. D. Isolation and synthesis of a hemoregulatory peptide. Z. Naturforsch. 37c:1297–1300; 1982.

    CAS  Google Scholar 

  78. Pereira-Smith, O. M.; Fisher, S. F.; Smith, J. R. Senescent and quiescent cell inhibitors of DNA synthesis. Membrane-associated proteins. Exp. Cell Res. 160:297–306; 1985.

    PubMed  CAS  Google Scholar 

  79. Peterson, S. W.; Lerch, V.; Moynaham, M. E., et al. Partial characterization of a growth-inhibitory protein in 3T3 cell plasma membranes. Exp. Cell Res. 142:447–451; 1982.

    PubMed  CAS  Google Scholar 

  80. Pigott, D. A.; Grimaldi, M. A.; Dell'aquila, M. L., et al. Growth inhibitors in plasma derived human serum. In Vitro 18:617–625; 1982.

    PubMed  CAS  Google Scholar 

  81. Podolsky, D. K.; Pleskow, D. K.; Jafari, H. Latent transformed growth-inhibiting factor in human malignant effusions. Cancer Res. 48:418–424; 1988.

    PubMed  CAS  Google Scholar 

  82. Roberts, A. B.; Anzano, M. A.; Wakefield, L. M., et al. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119–123; 1985.

    PubMed  CAS  Google Scholar 

  83. Roberts, A. B.; Sporn, M. B.; Assoian, R. K. Transforming growth factor-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167–4171; 1986.

    PubMed  CAS  Google Scholar 

  84. Roberts, A. B.; Sporn, M. B. Transforming growth factor β. Adv. Cancer Res. 51:107–145; 1988.

    PubMed  CAS  Google Scholar 

  85. Rollins, B. J.; Stiles, C. D. Regulation of c-myc and c-fos protooncogene expression by animal cell growth factors. In Vitro Cell. Develop. Biol. 24:81–84; 1988.

    CAS  Google Scholar 

  86. Russell, W. E.; Coffey, R. J., Jr.; Ouellette, A. J., et al. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85:5126–5130; 1988.

    PubMed  CAS  Google Scholar 

  87. Sasaki, T.; Shintani, M.; Kihara, K. Inhibition of growth of mammalian cell cultures by extracts of arginine-utilizing mycoplasmas. In Vitro 20:369–375; 1984.

    PubMed  CAS  Google Scholar 

  88. Schneider, C.; King, R. M.; Philipson, L. Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787–793; 1988.

    PubMed  CAS  Google Scholar 

  89. Schweigerer, L.; Neufeld, G.; Gospodarowicz, D. Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J. Clin. Invest. 80:1516–1520; 1987.

    PubMed  CAS  Google Scholar 

  90. Seyedin, S. M.; Segarini, P. R.; Rosen, D. M., et al. Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-β. J. Biol. Chem. 262:1946–1949; 1987.

    PubMed  CAS  Google Scholar 

  91. Sharifi, B. G.; Johnson, T. C.; Khurana, V. K. Purification and characterization of a bovine cerebral cortex cell surface sialoglycopeptide that inhibits cell proliferation and metabolism. J. Neurochem. 46:461–469; 1986.

    PubMed  CAS  Google Scholar 

  92. Sharma, C. P.; Gehring, H. A low molecular weight growth inhibitor secreted in cultures of chicken embryo fibroblasts. Biochem. Biophys. Res. Commun. 139:1243–1249; 1986.

    PubMed  CAS  Google Scholar 

  93. Shipley, G. D.; Pittelkow, M. R.; Wille, J. J., et al. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46:2068–2071; 1986.

    PubMed  CAS  Google Scholar 

  94. Shirasuna, K.; Morioka, S.; Watatani, K., et al. Growth inhibition and differentiation of human salivary adenocarcinoma cells by medium conditioned with normal human fibroblasts. Cancer Res. 48:2819–2824; 1988.

    PubMed  CAS  Google Scholar 

  95. Shoyab, M.; McDonald, V. L.; Bradley, J. G., et al. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc. Natl. Acad. Sci. USA 85:6528–6532; 1988.

    PubMed  CAS  Google Scholar 

  96. Shoyab, M.; Plowman, G. D.; McDonald, V. L., et al. Structure and function of human amphiregulin: A member of the epidermal growth factor family. Science 243:1074–1076; 1989.

    PubMed  CAS  Google Scholar 

  97. Sporn, M. B.; Roberts, A. B.; Wakefield, L. M., et al. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105:1039–1045; 1987.

    PubMed  CAS  Google Scholar 

  98. Sporn, M. B.; Roberts, A. B. Peptide growth factors are multifunctional. Nature 332:217–219; 1988.

    PubMed  CAS  Google Scholar 

  99. Silberstein, G. B.; Daniel, C. W. Reversible inhibition of mammary gland growth by transforming growth factor-β. Science 237:291–293; 1987.

    PubMed  CAS  Google Scholar 

  100. Stallcup, K. C.; Burakoff, S. J.; Mescher, M. F. Growth-inhibitory activity of lymphoid cell plasma membranes. II. Partial characterization of the inhibitor. J. Cell Biol. 99:1227–1234; 1984.

    PubMed  CAS  Google Scholar 

  101. Sugarman, B. J.; Aggarwal, B. B.; Hass, P. E., et al. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945; 1985.

    PubMed  CAS  Google Scholar 

  102. Takehara, K.; LeRoy, E. C.; Grotendorst, G. R. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49:415–422; 1987.

    PubMed  CAS  Google Scholar 

  103. Tanaka, A.; Matsuoka, H.; Uemura, H., et al. Production and characterization of tumor-degenerating factor. JNCL 74:575–581; 1985.

    CAS  Google Scholar 

  104. Terayama, H.; Koji, T.; Kotani, M., et al. Arginase as an inhibitory principle in liver plasma membranes arresting the growth of various mammalian cells in vitro. Biochim. Biophys. Acta 720:188–192; 1982.

    PubMed  CAS  Google Scholar 

  105. Tucker, R. F.; Shipley, G. D.; Moses, H. L., et al. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science 226:705–707; 1984.

    PubMed  CAS  Google Scholar 

  106. Vale, W.; Rivier, J.; Vaughan, J., et al. Purification and characterization of FSH releasing protein from porcine ovarian follicular fluid. Nature 321:776–779; 1986.

    PubMed  CAS  Google Scholar 

  107. Wang, J. L.; Hsu, Y.-M. Negative regulators of cell growth. TIBS 11:24–26; 1986.

    CAS  Google Scholar 

  108. Weiss, P.; Kavanau, J. L. A model of growth and growth control in mathematical terms. J. Gen. Physiol. 41:1–47; 1957.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kihara Institute for Biological Research, Yokohama City University, Nakamura-cho 2-120-3, Minami-ku, 232, Yokohama

    Kaoru Miyazaki

  2. Institute for Protein Research, Osaka University, Yamadaoka 3-2, Suita, 565, Osaka, Japan

    Takekazu Horio

Authors
  1. Kaoru Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takekazu Horio
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miyazaki, K., Horio, T. Growth inhibitors: Molecular diversity and roles in cell proliferation. In Vitro Cell Dev Biol 25, 866–872 (1989). https://doi.org/10.1007/BF02623997

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02623997

Keywords

Search

Navigation